Sign in

CIK 0001701108

  • Non-accelerated filer
  • Smaller reporting company

Spero Therapeutics, Inc.

Sign in to watch
Ticker
SPRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 857-242-1600
Business address
675 MASSACHUSETTS AVENUE, 14TH FLOOR, CAMBRIDGE, MA, 02139
Former names
Spero Therapeutics, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$42,485
in 1 filing

Net −$42,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Rajavelu Esther −$42K Reporting owner sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-08 Aquilo Capital Management, LLC 10% owner Sale −3,000 $21.74 $65K 3,829,209
2021-02-04 Aquilo Capital Management, LLC 10% owner Sale −34,144 $18.99 $648K 3,832,209
2021-02-03 Aquilo Capital Management, LLC 10% owner Sale −29,354 $18.98 $557K 3,866,353
2021-02-02 Aquilo Capital Management, LLC 10% owner Sale −22,841 $18.99 $434K 3,895,707
2021-02-01 Aquilo Capital Management, LLC 10% owner Sale −13,661 $19.24 $263K 3,918,548
2021-02-01 Keutzer Timothy Chief Development Officer Grant or award · Stock Option (Right to Buy) +57,432 57,432
2021-02-01 Larkin Cristina Chief Operating Officer Grant or award · Stock Option (Right to Buy) +57,432 57,432
2021-02-01 Mahadevia Ankit Grant or award · Stock Option (Right to Buy) +179,319 179,319
2021-02-01 Melnick David A. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +57,432 57,432
2021-01-04 VINK PATRICK V.J.J. Director Grant or award · Stock Option (right to buy) +1,314 $13.31 $17K 1,314
2021-01-04 Smith Cynthia Director Grant or award · Stock Option (right to buy) +2,629 $13.31 $35K 2,629
2021-01-04 THOMAS FRANK E Director Grant or award · Stock Option (right to buy) +1,314 $13.31 $17K 1,314
2021-01-04 Deshpande Milind Director Grant or award · Stock Option (right to buy) +2,629 $13.31 $35K 2,629
2021-01-04 Shukla Sath Chief Financial Officer Grant or award · Stock Option (right to buy) +75,000 75,000
2020-12-17 Aquilo Capital Management, LLC 10% owner Sale −250,000 $18.81 $4.7M 3,932,209
2020-12-16 Aquilo Capital Management, LLC 10% owner Sale −14,933 $18.62 $278K 4,182,209
2020-12-16 Larkin Cristina Chief Operating Officer Exercise or conversion +12,000 $5.90 $71K 13,500
2020-12-16 Larkin Cristina Chief Operating Officer Sale −12,000 $19.00 $228K 1,500
2020-12-16 Larkin Cristina Chief Operating Officer Exercise or conversion · Stock Option (Right to Buy) −12,000 8,434
2020-12-02 JOSEPH TAMARA L Chief Legal Officer Grant or award · Stock Option (right to buy) +75,000 75,000

Page 10 of 17 · 340 trades